Lebenthal Asset Management’s Medtronic MDT Stock Holding History

Lebenthal Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$2.19M	Buy	27,155 +1,378	+5%	+$108K	0.27%	116
2016 Q4	$1.84M	Buy	25,777 +8,730	+51%	+$686K	0.24%	129
2016 Q3	$1.47M	Sell	17,047 -9,765	-36%	-$851K	0.19%	163
2016 Q2	$2.33M	Buy	26,812 +4,398	+20%	+$356K	0.3%	110
2016 Q1	$1.68M	Buy	+22,414	New	+$1.69M	0.68%	43

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Lebenthal Asset Management's MDT Position: Q1 2017 in Review

Lebenthal Asset Management increased its Medtronic (MDT) stake by 5.3% in Q1 2017, buying an estimated $108K and bringing the position to 27,155 shares worth $2.19M. The position accounts for 0.27% of the portfolio, ranked #116.

Lebenthal Asset Management first reported a position in MDT in Q1 2016 and has held it in 5 quarters since. The position peaked at $2.33M in Q2 2016. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

Lebenthal Asset Management held 27,155 shares of Medtronic worth $2.19M as of Q1 2017.
Lebenthal Asset Management bought 1,378 Medtronic shares in Q1 2017, an estimated $108K.
Medtronic made up 0.27% of Lebenthal Asset Management's portfolio in Q1 2017, its #116 holding.
Lebenthal Asset Management first reported a position in Medtronic in Q1 2016 and has held it in 5 quarters since.
Lebenthal Asset Management's Medtronic position peaked at $2.33M in Q2 2016.
1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on Lebenthal Asset Management's 13F filing for Q1 2017, filed 15 May 2017.